Tsumura (FRA:TSUA) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TSUA Tsumura & Co FRA:TSUA
69 GF Score
Price €19.80
GF Value €21.71
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Tsumura Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:TSUA
69GF Score
Tsumura & Co FRA:TSUA
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tsumura (FRA:TSUA) Overvalued in 2026?

Based on GuruFocus' analysis, Tsumura stock appears to be undervalued. The current stock price of €19.80 is trading 8.8% below its estimated GF Value™ of €21.71. GuruFocus considers Tsumura to be Fairly Valued.

Key valuation signals for FRA:TSUA:

  • Interest Received:
  • GF Value™: €21.71 vs. price of €19.80 (8.8% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the FRA:TSUA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tsumura Business Description

Other Exchanges 4540:Japan
Address 2-17-11 Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates the majority of its revenue through prescription Kampo products, followed by over-the-counter medicines. It promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company specializes in developing, producing, and marketing Kampo formulations that integrate traditional herbal knowledge with modern pharmaceutical science to address various health conditions.
69GF Score

Get the complete analysis for FRA:TSUA

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.80
Price
€21.71
GF Value